Consolidated Balance Sheets - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Assets
Loans held for investment	$ 278,826,914	$ 196,984,566
Current expected credit loss reserve	(182,838)	(134,542)
Loans held for investment, net	278,644,076	196,850,024
Cash	6,078,178	80,248,526
Interest receivable	373,695	197,735
Other assets, net	795,754	868,022
Other receivables	16,201	6,148
Total Assets	285,907,904	278,170,455
Liabilities
Interest reserve	7,472,057	6,636,553
Dividend payable	7,125,661	4,537,924
Related party payable	682,344	1,902,829
Management and incentive fees payable	671,505	802,294
Accounts payable and accrued expenses	571,821	212,887
Total Liabilities	16,523,388	14,092,487
Commitments and contingencies (Note 8)
Stockholders’ equity
Common stock, par value $0.01 per share, 100,000,000 shares authorized at March 31, 2022 and December 31, 2021, respectively, and 17,752,603 and 17,453,553 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively	176,579	173,551
Additional paid-in-capital	268,681,445	264,081,977
Accumulated earnings (deficit)	526,492	(177,560)
Total stockholders’ equity	269,384,516	264,077,968
Total liabilities and stockholders’ equity	$ 285,907,904	$ 278,170,455